Concepts (184)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcinosis | 6 | 2015 | 59 | 1.480 |
Why?
|
| Macrophage Colony-Stimulating Factor | 5 | 2020 | 10 | 1.060 |
Why?
|
| Arteriosclerosis | 6 | 2004 | 36 | 1.010 |
Why?
|
| Osteoclasts | 2 | 2015 | 14 | 0.750 |
Why?
|
| Carotid Artery Injuries | 1 | 2016 | 4 | 0.560 |
Why?
|
| Giant Cells | 1 | 2015 | 13 | 0.540 |
Why?
|
| Carotid Artery Diseases | 1 | 2015 | 22 | 0.530 |
Why?
|
| Macrophages | 4 | 2020 | 439 | 0.510 |
Why?
|
| Muscle, Smooth, Vascular | 3 | 2020 | 130 | 0.510 |
Why?
|
| Lipoproteins, LDL | 3 | 2011 | 62 | 0.510 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2011 | 90 | 0.380 |
Why?
|
| Estradiol | 1 | 2011 | 262 | 0.350 |
Why?
|
| C-Reactive Protein | 2 | 2020 | 149 | 0.340 |
Why?
|
| Albuminuria | 3 | 2020 | 76 | 0.330 |
Why?
|
| Arteries | 3 | 2004 | 65 | 0.330 |
Why?
|
| Coronary Vessels | 3 | 2005 | 85 | 0.320 |
Why?
|
| Brachytherapy | 2 | 2004 | 7 | 0.270 |
Why?
|
| Gene Expression Regulation | 1 | 2011 | 1015 | 0.270 |
Why?
|
| Lipoproteins | 1 | 2005 | 64 | 0.250 |
Why?
|
| Endocrine System | 1 | 2004 | 11 | 0.250 |
Why?
|
| Matrix Metalloproteinase 3 | 2 | 2004 | 14 | 0.230 |
Why?
|
| Coronary Artery Disease | 1 | 2005 | 142 | 0.230 |
Why?
|
| Coronary Restenosis | 2 | 2004 | 25 | 0.230 |
Why?
|
| Membrane Glycoproteins | 3 | 2015 | 211 | 0.220 |
Why?
|
| Bone and Bones | 1 | 2003 | 86 | 0.220 |
Why?
|
| Inflammation Mediators | 2 | 2020 | 123 | 0.220 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 421 | 0.220 |
Why?
|
| Angioplasty, Balloon | 1 | 2002 | 4 | 0.210 |
Why?
|
| Mice | 8 | 2020 | 5913 | 0.190 |
Why?
|
| Animals | 13 | 2020 | 15081 | 0.190 |
Why?
|
| Immunoblotting | 2 | 2016 | 176 | 0.190 |
Why?
|
| Cell Membrane | 1 | 2002 | 381 | 0.180 |
Why?
|
| Mice, Knockout | 4 | 2020 | 933 | 0.180 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 1371 | 0.180 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2020 | 86 | 0.170 |
Why?
|
| Atherosclerosis | 1 | 2020 | 134 | 0.170 |
Why?
|
| Diabetic Nephropathies | 1 | 2019 | 61 | 0.170 |
Why?
|
| Inflammation | 1 | 2003 | 618 | 0.160 |
Why?
|
| Endothelial Cells | 2 | 2020 | 308 | 0.160 |
Why?
|
| Models, Biological | 1 | 2002 | 677 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 1609 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 448 | 0.150 |
Why?
|
| Male | 10 | 2020 | 20025 | 0.150 |
Why?
|
| Cells, Cultured | 4 | 2011 | 1518 | 0.140 |
Why?
|
| Rabbits | 1 | 2016 | 283 | 0.130 |
Why?
|
| Monocytes | 2 | 2011 | 257 | 0.130 |
Why?
|
| Humans | 12 | 2020 | 37093 | 0.130 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1198 | 0.130 |
Why?
|
| Female | 8 | 2020 | 20969 | 0.120 |
Why?
|
| Middle Aged | 5 | 2020 | 10129 | 0.120 |
Why?
|
| Diabetes Complications | 1 | 2014 | 90 | 0.110 |
Why?
|
| Kidney Failure, Chronic | 2 | 2014 | 233 | 0.110 |
Why?
|
| Aged | 4 | 2020 | 6741 | 0.110 |
Why?
|
| Apoptosis | 1 | 2020 | 1398 | 0.110 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2011 | 5 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2019 | 643 | 0.100 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2011 | 47 | 0.100 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2016 | 1618 | 0.100 |
Why?
|
| Free Radical Scavengers | 1 | 2011 | 66 | 0.100 |
Why?
|
| Acetylcysteine | 1 | 2011 | 62 | 0.090 |
Why?
|
| Apolipoproteins E | 3 | 2011 | 129 | 0.090 |
Why?
|
| Fatty Liver | 1 | 2011 | 64 | 0.090 |
Why?
|
| Dietary Fats | 1 | 2011 | 119 | 0.090 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 2379 | 0.090 |
Why?
|
| Muscle Development | 1 | 2008 | 45 | 0.080 |
Why?
|
| Follistatin | 1 | 2008 | 27 | 0.080 |
Why?
|
| beta Catenin | 1 | 2008 | 48 | 0.080 |
Why?
|
| Rats | 1 | 2016 | 3483 | 0.080 |
Why?
|
| Androgens | 1 | 2008 | 89 | 0.080 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 126 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2008 | 197 | 0.070 |
Why?
|
| Time Factors | 1 | 2011 | 1742 | 0.070 |
Why?
|
| Nutrition Surveys | 2 | 2020 | 242 | 0.070 |
Why?
|
| Tunica Intima | 2 | 2004 | 19 | 0.070 |
Why?
|
| Radiography, Thoracic | 1 | 2005 | 9 | 0.070 |
Why?
|
| Fatal Outcome | 1 | 2005 | 40 | 0.070 |
Why?
|
| Methods | 1 | 2005 | 13 | 0.060 |
Why?
|
| Preservation, Biological | 1 | 2005 | 3 | 0.060 |
Why?
|
| Lipoproteins, VLDL | 1 | 2005 | 3 | 0.060 |
Why?
|
| Anion Exchange Resins | 1 | 2005 | 4 | 0.060 |
Why?
|
| Chromatography, Gel | 1 | 2005 | 50 | 0.060 |
Why?
|
| Swine | 2 | 2004 | 184 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2011 | 938 | 0.060 |
Why?
|
| Heart Transplantation | 1 | 2005 | 42 | 0.060 |
Why?
|
| Specimen Handling | 1 | 2005 | 56 | 0.060 |
Why?
|
| Lipoproteins, HDL | 1 | 2005 | 46 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 217 | 0.060 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 25 | 0.060 |
Why?
|
| Echocardiography | 1 | 2005 | 144 | 0.060 |
Why?
|
| Thromboplastin | 1 | 2004 | 5 | 0.060 |
Why?
|
| Cell Differentiation | 2 | 2008 | 587 | 0.060 |
Why?
|
| Receptors, Immunologic | 1 | 2004 | 61 | 0.060 |
Why?
|
| Molecular Biology | 1 | 2004 | 46 | 0.060 |
Why?
|
| Catheterization | 1 | 2004 | 24 | 0.060 |
Why?
|
| Bone Development | 1 | 2003 | 15 | 0.060 |
Why?
|
| Aorta | 2 | 2020 | 167 | 0.060 |
Why?
|
| Receptors, Cell Surface | 1 | 2004 | 144 | 0.060 |
Why?
|
| Cholesterol | 1 | 2005 | 205 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2004 | 67 | 0.060 |
Why?
|
| Blotting, Western | 2 | 2004 | 859 | 0.060 |
Why?
|
| Immunohistochemistry | 2 | 2004 | 893 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2003 | 81 | 0.050 |
Why?
|
| Obesity | 1 | 2011 | 1067 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2002 | 150 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2002 | 56 | 0.050 |
Why?
|
| Osteopetrosis | 1 | 2002 | 2 | 0.050 |
Why?
|
| Receptor Activator of Nuclear Factor-kappa B | 1 | 2002 | 4 | 0.050 |
Why?
|
| Catalysis | 1 | 2002 | 179 | 0.050 |
Why?
|
| RANK Ligand | 1 | 2002 | 13 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 214 | 0.050 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2002 | 62 | 0.050 |
Why?
|
| Enzyme Activation | 1 | 2002 | 444 | 0.050 |
Why?
|
| Cell Division | 1 | 2002 | 307 | 0.050 |
Why?
|
| Flow Cytometry | 1 | 2002 | 399 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 448 | 0.050 |
Why?
|
| Receptors, LDL | 1 | 2020 | 30 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 356 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2020 | 51 | 0.050 |
Why?
|
| Microfilament Proteins | 1 | 2020 | 69 | 0.050 |
Why?
|
| Antigens, CD | 1 | 2020 | 121 | 0.050 |
Why?
|
| Cadherins | 1 | 2020 | 90 | 0.050 |
Why?
|
| Chronic Disease | 1 | 2003 | 484 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 305 | 0.040 |
Why?
|
| Signal Transduction | 3 | 2020 | 1908 | 0.040 |
Why?
|
| Urinalysis | 1 | 2019 | 30 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 400 | 0.040 |
Why?
|
| Creatinine | 1 | 2019 | 103 | 0.040 |
Why?
|
| Adult | 3 | 2020 | 11712 | 0.040 |
Why?
|
| Proportional Hazards Models | 1 | 2019 | 441 | 0.040 |
Why?
|
| RNA, Messenger | 1 | 2002 | 1207 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2002 | 1369 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 753 | 0.040 |
Why?
|
| Child | 1 | 2005 | 3131 | 0.040 |
Why?
|
| Incidence | 1 | 2019 | 922 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 885 | 0.030 |
Why?
|
| Glomerular Filtration Rate | 1 | 2014 | 139 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 2721 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 3562 | 0.030 |
Why?
|
| Selenomethionine | 1 | 2011 | 10 | 0.020 |
Why?
|
| Lipogenesis | 1 | 2011 | 18 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 31 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 77 | 0.020 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 95 | 0.020 |
Why?
|
| Hepatocytes | 1 | 2011 | 75 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2011 | 227 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2011 | 152 | 0.020 |
Why?
|
| United States | 1 | 2020 | 4223 | 0.020 |
Why?
|
| TCF Transcription Factors | 1 | 2008 | 15 | 0.020 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2008 | 17 | 0.020 |
Why?
|
| Receptor Cross-Talk | 1 | 2008 | 17 | 0.020 |
Why?
|
| Orchiectomy | 1 | 2008 | 35 | 0.020 |
Why?
|
| Protein Transport | 1 | 2008 | 302 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 366 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2008 | 409 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2008 | 360 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2004 | 16 | 0.020 |
Why?
|
| Interleukin-12 | 1 | 2004 | 47 | 0.020 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2004 | 41 | 0.020 |
Why?
|
| Pyrophosphatases | 1 | 2004 | 7 | 0.010 |
Why?
|
| Tunica Media | 1 | 2004 | 12 | 0.010 |
Why?
|
| Toll-Like Receptors | 1 | 2004 | 51 | 0.010 |
Why?
|
| E-Selectin | 1 | 2004 | 21 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2004 | 19 | 0.010 |
Why?
|
| Coronary Thrombosis | 1 | 2004 | 6 | 0.010 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2004 | 31 | 0.010 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 62 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2004 | 26 | 0.010 |
Why?
|
| Cyclooxygenase 2 | 1 | 2004 | 104 | 0.010 |
Why?
|
| Isoenzymes | 1 | 2004 | 161 | 0.010 |
Why?
|
| Young Adult | 1 | 2014 | 4268 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 70 | 0.010 |
Why?
|
| Calcium-Binding Proteins | 1 | 2004 | 76 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2004 | 149 | 0.010 |
Why?
|
| Lipid Metabolism | 1 | 2004 | 119 | 0.010 |
Why?
|
| Chemokine CCL2 | 1 | 2004 | 85 | 0.010 |
Why?
|
| Estrogen Receptor alpha | 1 | 2004 | 111 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 156 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2004 | 190 | 0.010 |
Why?
|
| Lipids | 1 | 2004 | 235 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 237 | 0.010 |
Why?
|
| Phenotype | 1 | 2004 | 689 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2004 | 517 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2004 | 767 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2004 | 485 | 0.010 |
Why?
|